The current TAK market cap is 20.6B. The company's latest EPS is JPY 200.3525 and P/E is 0.25.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Total Revenue | 1.01T | 1.1T | 962.81B | 1.06T | 1.05T |
Operating Income | 103.57B | 145.22B | 80.97B | 168.15B | -47.32B |
Net Income | 61.74B | 119.13B | 31.13B | 89.4B | -48.03B |
Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Total Revenue | 2.15T | 3.35T | 3.28T | 3.61T | 4.05T |
Operating Income | 58.4B | 70.72B | 275.69B | 438.73B | 479.78B |
Net Income | 109.13B | 44.24B | 376.01B | 230.06B | 317.02B |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Total Assets | 14.59T | 13.5T | 13.96T | 14.79T | 14.87T |
Total Liabilities | 7.88T | 7.33T | 7.6T | 7.87T | 7.8T |
Total Equity | 6.71T | 6.18T | 6.35T | 6.92T | 7.07T |
Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Total Assets | 13.87T | 12.82T | 12.91T | 13.18T | 13.96T |
Total Liabilities | 8.71T | 8.09T | 7.74T | 7.49T | 7.6T |
Total Equity | 5.16T | 4.73T | 5.18T | 5.68T | 6.35T |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Operating | 305.24B | 683.46B | 977.16B | 92.4B | 291.3B |
Investing | -121.92B | -168.61B | -607.1B | -266.52B | -327.11B |
Financing | -267.59B | -702.55B | -709.15B | -57.78B | -198.43B |
Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Operating | 328.48B | 669.75B | 1.01T | 1.12T | 977.16B |
Investing | -2.84T | 292.12B | 393.53B | -198.13B | -607.1B |
Financing | 2.95T | -1.01T | -1.09T | -1.07T | -709.15B |
Market Cap | 20.6B |
Price to Earnings Ratio | 0.25 |
Price to Sales Ratio | 0.02 |
Price to Cash Ratio | 0.15 |
Price to Book Ratio | 0.01 |
Dividend Yield | - |
Shares Outstanding | 1.58B |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.53 (3.91%) |
Company Name | Takeda Pharmaceutical Company Ltd |
Address |
4-1-1 doshomachi chuo, tokyo 540-8645 |
Website | https://www.takeda.co.jp |
Industry | pharmaceutical diversified (H2) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.